1888 Press Release | Envisioneering Medical Technologies Press Releases

Envisioneeringmedical.com - Envisioneering Medical Technologies Company News Section

Envisioneering Medical Technologies Information

Meg Fullenkamp

1982 Innerbelt Business Center Drive St. Louis, Mo
Phone: 314-429-7367
URL: http://www.envisioneeringmedical.com/

Envisioneering Medical Technologies, based in St. Louis, Mo., offers technology to support the continuum of care for the prostate â€“ from accurate biopsies to targeted cancer treatment. TargetScan Touchâ„¢ was introduced in late 2008, incorporating a touch-screen interface with the TargetScanÂ® Ultrasound Probe technology platform. For more information please visit www.envisioneeringmedical.com.

Envisioneering Medical Technologies Press Release -

Envisioneeringmedical.com

01 May	Study Highlights TargetScan Touch for Improved Prostate Cancer Detection
	A recent Duke University study confirms that the TargetScan Touch technology by Envisioneering Medical Technologies offers effective detection and treatment of prostate cancer. A study published by Duke University in the April 2009 edition of Technology in Cancer Research and Treatment, confirms that TargetScan® stereotactic ...

01
APR

Study Shows Stereotactic Biopsy System Delivers Greater Accuracy in Detecting Cancer and Planning for Targeted Prostate Cancer Therapies

The study, titled TargetScan: A Novel Approach for Outpatient Prostate Biopsy and Potential Aid to Focal Prostate Therapy, analyzed 50 men receiving first-time biopsies at Midtown Urology Surgical Center in Atlanta and showed that the TargetScan stereotactic method identifying sample locations in 3-dimensional detail delivered cancer detection results comparable to other methods.

Urologists convening this week at the Southeast Conference of the American Urologic Association (AUA) in Mobile will deliver results from a study of a ...

12 MAR	Targeted Prostate Cancer Biopsy And Cancer Treatment Earns Acceptance From Nation’s Top Prostate Specialists
	TargetScan, developed by Envisioneering Medical Technologies, accurately maps the prostate and precisely targets specific locations on the prostate. To date, more than 3,500 prostate biopsies and subsequent cancer treatment procedures have been conducted using the proprietary TargetScan technology, ...